Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations

Sapio Sciences, the science-aware™ lab informatics platform, today announced it has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients

Owkin’s MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of Proscia’s precision medicine AI portfolio.

Future Fields Debuts Instar 1.0: A Biofactory With 30 Times the Output of Conventional Protein Technology

Recombinant protein biomanufacturer debuts factory and new product line

Oregon Freeze Dry Brings in New Leadership

Life Sciences CDMO Veteran David Enloe Appointed CEO of OFD.

Cotiviti to Launch End-to-End Healthcare Fraud Solution at 2024 NHCAA Annual Training Conference

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Introducing FlexFactory to Poland, delivered by Cytiva and operated by SyVento Biotech

2BScientific limited announces opening of a new European hub in Germany

2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.

SynbiCITE awarded £3m EPSRC grant to expand engineering biology proof-of-concept programme

SynbiCITE, the U.K.’s National Industrial Translation Centre for Engineering Biology, has been awarded a grant of £3m to expand its Proof-of-Concept (PoC) programme for start-up engineering biology companies.

Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Healthcare Agency Veteran Allison Davis Joins CG Life as Chief Client Officer

CG Life, a leading integrated agency that blends strategy, creative, marketing, digital, and communications with science, has welcomed Allison Davis to the agency’s newly created role of Chief Client Officer.

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

Ansa Biotechnologies just announced that it can deliver its Clonal DNA product in lengths up to 5kb. The longer constructs are made possible due to a new proprietary, sequence-agnostic assembly technology. The complete platform allows Ansa to produce long, complex DNA more accurately and reliably than any other DNA synthesis vendor.

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for DKD. MultiOmic’s CEO Robert Thong will present these findings at the LSX Investival Conference in London on 18th November 2024.

Rousselot and IamFluidics Launch Revolutionary Dissolvable Microcarrier for Scalable Cell Culturing

Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production.